trial

EPI-MINN: Targeting Cognition and Motivation - National

NCTId NCT05877716
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 200 (estimated)
Sponsored by University of Minnesota
Primary completion 2026-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-05-30
Primary completion
2026-06-30
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
Cognitive and Social Cognitive TrainingPersonalized Real-Time Intervention for Motivational Enhancement (PRIME) AppEarly Psychosis Coordinated Specialty Care

Sponsors

University of MinnesotaLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
Sophia Vinogradov, MDPrincipal Investigator
Piper S Meyer-Kalos, PhDPrincipal Investigator

Sites

1 total
Minneapolis, United States

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2026-06-30
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Cognitive and Social Cognitive Training
drug
Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App
drug
Early Psychosis Coordinated Specialty Care
drug
lead_sponsor
University of Minnesota
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Unspecified Psychosis
indication
investigator
Sophia Vinogradov, MD
person
Piper S Meyer-Kalos, PhD
person